DRO1 sensitizes colorectal cancer cells to receptor-mediated apoptosis

  • Authors:
    • Andreas Herbst
    • Constanze Bayer
    • Claudia Wypior
    • Frank T. Kolligs
  • View Affiliations

  • Published online on: July 5, 2011     https://doi.org/10.3892/ol.2011.356
  • Pages: 981-984
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The molecule DRO1 (down‑regulated by oncogenes 1) is a potential tumor suppressor protein that is frequently down‑regulated in primary colorectal cancers and colorectal cancer cell lines. Although the mechanism of DRO1 action has yet to be elucidated, previous data have suggested that DRO1 interferes with tumor growth by sensitizing cells to apoptosis. The effect of DRO1 expression on receptor-, mitochondrial- and endoplasmic reticulum‑mediated apoptosis in colorectal cancer cell lines was analyzed in this study, following the generation of DLD1/DRO1 and HCT116/DRO1 cell lines. Cells were cultured, and then analyzed using flow cytometry. DRO1 was found to sensitize cells to receptor-mediated apoptosis by promoting the activation of components of the death-inducing signaling complex (DISC).

Related Articles

Journal Cover

September-October 2011
Volume 2 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Herbst A, Bayer C, Wypior C and Kolligs FT: DRO1 sensitizes colorectal cancer cells to receptor-mediated apoptosis. Oncol Lett 2: 981-984, 2011
APA
Herbst, A., Bayer, C., Wypior, C., & Kolligs, F.T. (2011). DRO1 sensitizes colorectal cancer cells to receptor-mediated apoptosis. Oncology Letters, 2, 981-984. https://doi.org/10.3892/ol.2011.356
MLA
Herbst, A., Bayer, C., Wypior, C., Kolligs, F. T."DRO1 sensitizes colorectal cancer cells to receptor-mediated apoptosis". Oncology Letters 2.5 (2011): 981-984.
Chicago
Herbst, A., Bayer, C., Wypior, C., Kolligs, F. T."DRO1 sensitizes colorectal cancer cells to receptor-mediated apoptosis". Oncology Letters 2, no. 5 (2011): 981-984. https://doi.org/10.3892/ol.2011.356